Evidence map›Paper›PMID 30021842›Full record

ArticleDevelopment (Cambridge, England)2018

SOX9 is dispensable for the initiation of epigenetic remodeling and the activation of marker genes at the onset of chondrogenesis.

Chia-Feng Liu, Marco Angelozzi, Abdul Haseeb, Véronique Lefebvre

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Early determination of the dorsal-ventral axis in endochondral ossification in mice.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Methylphenidate Promotes Premature Growth Plate Closure: In Vitro Evidence.International journal of molecular sciences · 2023
    Article
  9. Hypomorphic and dominant-negative impact of truncated SOX9 dysregulates Hedgehog-Wnt signaling, causing campomelia.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. SOX9 and SOX10 control fluid homeostasis in the inner ear for hearing through independent and cooperative mechanisms.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. SOX9 in organogenesis: shared and unique transcriptional functions.Cellular and molecular life sciences : CMLS · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Transcriptional networks controlling stromal cell differentiation.Nature reviews. Molecular cell biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chia-Feng LiuDepartment of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
Marco AngelozziDepartment of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
Abdul HaseebDepartment of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
Véronique LefebvreDepartment of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA lefebvrev1@email.chop.edu.ORCID 0000-0003-3063-4031
Cleveland Clinic Lerner College of Medicine · US

Funding

Sox9-mediated control of chondrogenesisR01AR046249 · NIAMS · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI LEFEBVRE, VERONIQUE M · 1999 to 2015
$4.9M
Roles of SOXC proteins in osteogenic cellsR01AR068308 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI LEFEBVRE, VERONIQUE M · 2016 to 2020
$2.4M
Spinning Disk Confocoal MicroscopeS10RR026820 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI DRAZBA, JUDY · 2010 to 2010
$500k
NCRR NIH HHS S10 RR026820NIAMS NIH HHS R01 AR046249NIAMS NIH HHS R01 AR068308
6 · The paper itself

Abstract

SOX9 controls cell lineage fate and differentiation in major biological processes. It is known as a potent transcriptional activator of differentiation-specific genes, but its earliest targets and its contribution to priming chromatin for gene activation remain unknown. Here, we address this knowledge gap using chondrogenesis as a model system. By profiling the whole transcriptome and the whole epigenome of wild-type and

Indexed as

AnimalsChondrogenesisChromatin Assembly and DisassemblyEmbryo, MammalianEpigenesis, GeneticGene Expression Regulation, DevelopmentalLimb BudsMiceMice, TransgenicMicrofilament ProteinsMyosin Heavy ChainsMyosin Type IINerve Tissue ProteinsSOX9 Transcription FactorFAM101A protein, mouseMicrofilament ProteinsMyh14 protein, mouseMyosin Heavy ChainsMyosin Type IINerve Tissue ProteinsSox9 protein, mouseSOX9 Transcription FactorChondrogenesisEpigenetic regulationPioneer transcription factorPrecartilaginous condensationSOX9

Identifiers

PMID30021842
PMCPMC6078338
OpenAlexW2884620368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.